Vemuru, Shalini
Kalinsky, Kevin
Bhave, Manali
Article History
Accepted: 25 July 2024
First Online: 17 October 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Vemuru has no conflict of interest. Dr. Bhave reports consulting fees from Eli Lilly, Gilead, Merck, Astrazeneca, Daiichi Sankyo, and Pfizer, outside the submitted work. Dr. Kalinsky reports grants from Genentech/Roche, Immunomedics, Seattle Genetics, Daiichi Sankyo, Puma Biotechnology, Mersana, Menarini Silicon Biosystems, Myovant Sciences, Takeda, and personal fees from EQRX, ADC Therapeutics (Spouse: Employee), during the conduct of the study.